Chenguang Biotech Group Co., Ltd.

  • Market Cap: Small Cap
  • Industry: FMCG
  • ISIN: CNE100000WC5
CNY
11.41
0.16 (1.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
6,554.74
6,975.01
6,869.39
6,292.42
4,871.58
3,909.87
3,262.74
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,554.74
6,975.01
6,869.39
6,292.42
4,871.58
3,909.87
3,262.74
Raw Material Cost
5,743.90
6,487.04
6,115.60
5,465.17
4,196.01
3,290.85
2,706.31
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
247.98
216.95
221.41
198.48
213.64
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
95.61
118.38
85.40
68.91
54.37
79.31
66.45
Selling and Distribution Expenses
199.72
170.52
180.32
212.36
173.54
177.16
252.11
Other Expenses
-18.38
-21.25
-21.49
-14.51
-18.17
-0.31
-2.17
Total Expenditure (Excl Depreciation)
6,103.42
6,780.41
6,387.81
5,799.78
4,455.82
3,544.25
3,003.14
Operating Profit (PBDIT) excl Other Income
451.3
194.60000000000002
481.59999999999997
492.59999999999997
415.79999999999995
365.6
259.6
Other Income
102.96
101.24
143.50
102.27
62.09
53.41
28.93
Operating Profit (PBDIT)
697.48
388.63
776.89
695.67
578.71
503.14
362.64
Interest
95.61
118.38
85.40
68.91
54.37
79.31
66.45
Exceptional Items
8.23
-4.77
4.24
-6.35
-13.87
-9.15
-2.20
Gross Profit (PBDT)
810.85
487.98
753.79
827.25
675.57
619.02
556.43
Depreciation
184.45
167.15
153.03
145.32
130.51
112.29
88.80
Profit Before Tax
425.65
98.33
542.70
475.09
379.96
302.39
205.20
Tax
62.99
28.99
61.65
65.67
47.47
46.49
20.71
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
368.87
94.05
479.72
434.03
351.51
267.74
193.57
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
368.87
94.05
479.72
434.03
351.51
267.74
193.57
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
6.00
-16.09
14.45
2.05
-0.92
-1.60
-3.72
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
374.88
77.96
494.17
436.09
350.60
266.14
189.85
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,389.11
3,109.49
3,470.47
3,164.82
2,785.48
2,064.14
1,748.10
Earnings per share (EPS)
0.76
0.18
0.9
0.81
0.67
0.53
0.39
Diluted Earnings per share
0.76
0.18
0.9
0.81
0.67
0.53
0.39
Operating Profit Margin (Excl OI)
6.26%
1.72%
6.99%
7.12%
7.93%
8.63%
7.51%
Gross Profit Margin
9.31%
3.81%
10.13%
9.86%
10.48%
10.61%
9.01%
PAT Margin
5.63%
1.35%
6.98%
6.9%
7.22%
6.85%
5.93%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -6.03% vs 1.54% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 380.64% vs -84.22% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 106.85% vs -54.63% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -19.26% vs 38.64% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Chenguang Biotech Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
6,554.74
0
6,554.74
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,554.74
0
6,554.74
Raw Material Cost
5,743.90
0
5,743.90
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
247.98
0
247.98
Power Cost
0
0
0.00
Manufacturing Expenses
95.61
0
95.61
Selling and Distribution Expenses
199.72
0
199.72
Other Expenses
-18.38
0.00
-18.38
Total Expenditure (Excl Depreciation)
6,103.42
0
6,103.42
Operating Profit (PBDIT) excl Other Income
451.32
0.00
451.32
Other Income
102.96
0
102.96
Operating Profit (PBDIT)
697.48
0
697.48
Interest
95.61
0
95.61
Exceptional Items
8.23
0
8.23
Gross Profit (PBDT)
810.85
0
810.85
Depreciation
184.45
0
184.45
Profit Before Tax
425.65
0
425.65
Tax
62.99
0
62.99
Provisions and contingencies
0
0
0.00
Profit After Tax
368.87
0
368.87
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
368.87
0
368.87
Share in Profit of Associates
0
0
0.00
Minority Interest
6.00
0
6.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
374.88
0
374.88
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,389.11
0
3,389.11
Earnings per share (EPS)
0.76
0
0.76
Diluted Earnings per share
0.76
0
0.76
Operating Profit Margin (Excl OI)
6.26%
0%
0.00
6.26%
Gross Profit Margin
9.31%
0%
0.00
9.31%
PAT Margin
5.63%
0%
0.00
5.63%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 655.47 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -6.03% vs 1.54% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 37.49 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 380.64% vs -84.22% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 59.45 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 106.85% vs -54.63% in Dec 2024

Annual - Interest
Interest 9.56 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -19.26% vs 38.64% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.26%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024